The present study is – to the authors’ knowledge – the first systematic review on the utilization of staged surgical approaches for the resection of intra-axial (as opposed to extra-axial skull-base) neoplasms. There are a limited number of reported cases in the literature regarding surgical staging for intracranial neoplasms, with case reports or single-institutional retrospective case series comprising the majority. We observed that, in recent years, most staged intracranial surgeries for intra-axial neoplasms were performed within the pediatric patient population. Additionally, we found that neither the timing between staged procedures nor the associated cost of surgery were consistently reported in the included studies. The complications described for multi-staged approaches included neurological deficits that have previously been described for these same approaches when employed as a single stage.24 Furthermore, no obvious complications occurred as a result of prolonged anesthesia, multiple inductions of anesthesia, peri-operative infections, or other complications associated with multiple procedures and/or hospitalizations. This systematic review highlights the paucity of data available on staged intra-axial tumor surgery and provides some evidence that performing a staged approach does not yield a significant increase in complications.
Although surgeries for large skull-base tumors are often staged successfully, staged surgeries for intra-axial tumors are rarely done intentionally, rather these tumors undergo second operations because residual tumor is found and associated with worse survival outcomes. 1–6 Dandy first described the utilization of staged surgical resection for large tumors in 1925, there has been a relative scarcity of large case series presenting clinical outcomes for patients undergoing multiple-stage operations for the resection of intra-axial neoplasms. The majority of the published data on staged cranial surgeries has focused on benign extra-axial lesions such as petroclival meningiomas,3 vestibular schwannomas,25 trigeminal schwannomas,26 and pituitary adenomas.27
Intracranial tumors that may require staging are those that are slow-growing and reach a large tumor volume at time of symptom onset. Tumors like glioblastomas are typically not resected through staged approaches due to rapid growth, and symptom onset with tumor volumes of 35 cm3 on average.3–6 For example, in 1995 Comey et al. reported on 83 vestibular schwannoma patients who underwent staged resection, noting that residual tumor in the second stage was less tightly adherent to the brain stem.28 Furthermore, in 2012 Raslan et al. reported that staged resection of large vestibular schwannomas improved facial nerve outcomes without added morbidity.4
In 1998, Nakase et al. reported on staged surgical resection of skull base tumors extending into the sub- and epidural spaces, and demonstrated that the blood supply to the tumors decreased following resection of the epidural tumor following the first operation.27 Furthermore, the residual subdural tumors were soft and less vascular in the second stage which facilitated tumor resection. In 1990, Sekhar et al. reported on 41 patients with clival meningiomas and noted that staged operations, in conjunction with specific approaches and surgeon experience, correlated with fewer postoperative complications.29
At present, reported outcomes on staged intracranial surgeries are mostly limited to small single-institutional case series and case reports. Many of these cases are benign intracranial neoplasms, with a small subset of malignant neoplasms reported in the pediatric population. Although multiple-staged surgeries may carry an increased risk of infection and venous thromboembolism, the argument in support of their utilization centers around planning multiple operations for maximum safe resection. While doing so theoretically poses an additional operative risk, it can be argued that potential benefits may outweigh long-term consequences of subtotal resection and subsequent recurrence.36
Furthermore, increased risk of surgical infection in staged surgeries is theoretical and has never been established. In our review, we found no case of reported peri-operative infection in any staged surgery patient. Additionally, the benefits of a single, long-duration surgery, as opposed to numerous shorter surgeries, remain unclear. It can be argued that a single surgery may be more cost-effective and pose less risk with respect to intra- and post-operative complications, however, the risk of intraoperative complications correlates with surgical length, and the patient may actually benefit from two shorter procedures as opposed to one longer procedure.30 Additionally, studies comparing costs between single and multi-staged surgeries are required before definitive conclusions regarding cost-effectiveness can be made.
Interestingly, the cost is not the only gray area in need of further evaluation as the optimal timing between individual components of a multiple-stage surgery remains poorly understood. The second operation would ideally be performed prior to the development of scar tissue or revascularization of the tumor. From the limited data currently available, Comey et al. reported an inter-stage interval ranging from 0.5 to 32 weeks (mean: 4.5 weeks), dependent upon computed tomography (CT) imaging demonstrating less brain stem compression from the tumor.28 By contrast, Nakase et al. reported an inter-stage interval ranging from 4 to 12 weeks (mean: 5.9 weeks).27 As more robust evidence is required before consensus statement can be offered, further investigation into the optimal inter-stage timing between procedures is warranted. In our study, timing between surgeries varied from 5 days to a few weeks in pediatric patients and 18 days to four months in adult patients with no clear benefit for any timeframe reported.
With respect to the clinical reasoning behind staging cranial surgery, there are several indications for staged approaches to the resection of primary CNS neoplasms. First, staged surgery may be indicated for large volume tumors in which initial tumor debulking allows for removal of a large percentage of the tumor, after which tumor tissue and cleavage plan are easier to recognize due to time elapsed prior to the subsequent surgery (and the resulting cessation of irritation of the surgical space).31 Furthermore, in a study on the extent of resection of diffuse intra-axial tumors, Kavouridis et al. reported that higher preoperative tumor volume and higher postoperative tumor residuals were associated with worse overall survival, progression-free survival, and malignant progression-free survival32. This trend was evident across all intra-axial neoplasms but was distinctly pronounced in more aggressive astrocytoma subtypes. These results indicate that staged resection may be favored when attempting maximum safe resection for astrocytomas and other high-grade lesions. In their report on an atypical choroid plexus papilloma, Takahashi and colleagues suggested that the exceptionally vascular nature of the tumor described ultimately led to their decision to stage surgery.14 Similar reports in the literature describe instances in which significant vascularity of intra-axial tumors has led to the decision to pursue a staged surgery intraoperatively. Kumabe et al. reported a case in which multi-stage surgery separating debulking and subcortical mapping was used in a case of anaplastic astrocytoma, and gross total resection without neurological deficit was achieved.17 In the studies analyzed in our review, we discovered pediatric intra-axial tumors were staged for two reasons. First, is the intraoperative concern of hemorrhage during the surgery, leading to profound hypotension and inability to continue the resection safely. This led neurosurgeons to prematurely stop resection and continue total removal through a second staged procedure. The second reason reported is planned staging due to large tumors requiring resection around eloquent areas of speech and motor cortices that allowed for awake functional mapping after a primary resection around less eloquent structures.20
Potential indications for staged surgery for lower-grade gliomas have been previously discussed in the literature, including size > 100 cm3, multi-lobar (e.g. fronto-temporo-insular, temporo-parietal-occipital) extension, and intervening eloquent fasciculi and/or critical neurovascular structures that create an anatomic partition.8 Further indications may be ascertained from reports regarding the staging of complex skull base procedures, which are far more commonly described than staged surgery for intraparenchymal lesions. For example, it is notable that Nakamura utilized a staged retrosigmoid lateral suboccipital and frontolateral approach to remove a retrosellar upper clival meningioma extending to the suprasellar region in order to minimize the disruption of venous drainage and damage to surrounding neurovascular structures.15 Additionally, Xu and colleagues reported that resection of petroclival meningiomas using staged orbitozygomatic and retrosigmoid approaches require separate procedures, incisions, and general anesthetic inductions that may not be beneficial unless an experienced neurootologist is available for temporal bone exposure.33 Ogiwara et al. reported a single case in which a staged surgery was employed in order to mitigate blood loss that occurred intraoperatively during the first surgery in a pediatric patient with a choroid plexus papilloma.21 Futhermore, Nkusi et al. reported on 12 patients with staged meningioma resection, with a subset of patients in which the decision to stage surgery was made intraoperatively.19 This decision was based on the presence of cerebral edema, profuse bleeding with hemodynamic instability, and tumor abutment into cranial nerves (e.g., in the case of CPA tumors). Nakamura et al. report that an intraoperative decision to stage a surgery for supratentorial anaplastic ependymoma was made based on tumor hypervascularity, size, and location.15 Todeschini et al. reported that the second stage of a giant olfactory groove meningioma resulted in relaxation of brain tissue, less edema, reduced need for retraction, and facilitation of gross total resection.34 Finally, staged surgery may be all but required for particularly expansive or complex lesions occupying more than one compartment. For example, Foreman describes utilization of a two-stage approach in for resection of an atypical teratoid rhabdoid tumor occupying the supra- and infratentorial compartments in a pediatric patient.18
In their study on staged surgery for patients with glomus jugulare tumors with significant intracranial extension, Jayashankar and colleagues provide their reasons for staging surgery as a summary rationale that draws upon the main takeaway indications for staging surgery. These include 1) removal of extensive intracranial lesions in close proximity to the lower cranial nerves; 2) devascularization of the tumor during the first stage to decrease intraoperative hemorrhage during the second stage (also causes the tumor to shrink and facilitates excision); and 3) to facilitate the sealing of dural defects in the second stage due to a smaller area of exposure.35 Complete resection by staged surgeries has been associated with minimized operative morbidity and improved long-term clinical outcomes, therefore staging may be an important tool to fully resect intra-axial tumors.1,2,7
Limitations
This systematic review presents a few limitations worth discussing. First, due to the paucity of literature available on the topic, making definite conclusions is quite arduous. Future prospective evaluations comparing complication profiles of patients undergoing staged versus non-staged resections for large intracranial tumors are warranted. As has been previously noted, the available literature describing the exact parameters in which staged surgery for primary intra-axial brain lesions is indicated is a shortcoming.36 Furthermore, another data limitation is that many studies omitted specific characteristics of their patient cohorts or related outcomes making comparisons between single and multi-staged surgery difficult. Additionally, due to reporting within the studies, we did not find any papers that included both staged and non-staged procedures to accurately compare via meta-analysis the complication profiles between these approaches. As such, this topic warrants future investigation via retrospective cohort studies and prospective randomized clinical trials comparing single versus staged surgical resections.37–41 Unfortunately, we were not able to compare complication profiles between pediatric and adult cases as our cohort size for adults was limited to 4 patients. Finally, none of the papers in our review discussed differences in cost between single versus staged procedures. Future studies should elucidate this difference and assess for cost-effectiveness of staged cranial surgery for primary brain lesions. Nonetheless, despite these limitations, our study provides the first systematic review on staged intracranial tumor resection reporting on the surgical indications, timing between surgeries, surgical approaches, complication profiles, and clinical outcomes staged approaches to resection of intra-axial lesions.